Stay updated on Magrolimab in Hematological Malignancies Clinical Trial

Sign up to get notified when there's something new on the Magrolimab in Hematological Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Magrolimab in Hematological Malignancies Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.
    Difference
    0.7%
    Check dated 2025-05-30T13:08:21.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-23T10:32:32.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-05-01T23:26:53.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study objectives and inclusion/exclusion criteria for a clinical trial on magrolimab, while adding a new section on hematological malignancies and an updated revision number.
    Difference
    9%
    Check dated 2025-04-17T11:01:58.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date of January 17, 2025, has been added. However, the deletion of the date March 25, 2025, does not significantly impact the core content.
    Difference
    0.3%
    Check dated 2025-04-10T05:40:36.000Z thumbnail image
  7. Check
    95 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.7%
    Check dated 2025-02-25T19:07:01.000Z thumbnail image

Stay in the know with updates to Magrolimab in Hematological Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Magrolimab in Hematological Malignancies Clinical Trial page.